Peter Horvath Selected Research

(2- fluoromethoxy- 5- (5- trifluoromethyltetrazol- 1- yl)benzyl)(2- phenylpiperidin- 3- yl)amine

11/2019

Spa-RQ: an Image Analysis Tool to Visualise and Quantify Spatial Phenotypes Applied to Non-Small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Horvath Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 02/2013
4	Melanoma (Melanoma, Malignant) 01/2022 - 10/2019
3	Inflammation (Inflammations) 12/2018 - 04/2006
3	Infections 01/2016 - 08/2014
2	Obstructive Sleep Apnea 01/2021 - 12/2018
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
2	Obesity 01/2019 - 01/2017
2	Hypertension (High Blood Pressure) 12/2018 - 01/2017
2	Leukemia 01/2017 - 11/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 11/2014
2	Hyperglycemia 02/2015 - 08/2013
1	Hypercholesterolemia 02/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2022
1	Genetic Risk Score 02/2022
1	Disease Progression 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	COVID-19 11/2020
1	Brain Neoplasms (Brain Tumor) 07/2020
1	Lymphoma (Lymphomas) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Body Weight (Weight, Body) 12/2018
1	Hyperalgesia 01/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	MYH9-Related Disorders 01/2017
1	Phototoxic Dermatitis (Phototoxicity) 01/2016
1	Chromosome Duplication 01/2015
1	Bunyaviridae Infections 08/2014
1	Gastroesophageal Reflux (GERD) 06/2014
1	Barrett Esophagus (Barrett's Esophagus) 06/2014
1	Glioma (Gliomas) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 08/2013
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Wounds and Injuries (Trauma) 01/2012

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2013
4	LipidsIBA 02/2020 - 02/2015
3	ProteomeIBA 01/2022 - 01/2021
3	Complement System Proteins (Complement)IBA 01/2021 - 12/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Biological ProductsIBA 06/2021 - 01/2020
2	SurvivinIBA 01/2021 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 07/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2016
1	oxidized low density lipoproteinIBA 02/2022
1	LDL CholesterolIBA 02/2022
1	InterferonsIBA 01/2022
1	ClusterinIBA 01/2021
1	Complement Factor H (Factor H)IBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	PlatinumIBA 01/2021
1	Neuropilin-1IBA 11/2020
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020
1	rac1 GTP-Binding ProteinIBA 01/2020
1	Syndecan-4IBA 01/2020
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2020
1	Monomeric GTP-Binding ProteinsIBA 01/2020
1	(2- fluoromethoxy- 5- (5- trifluoromethyltetrazol- 1- yl)benzyl)(2- phenylpiperidin- 3- yl)amineIBA 11/2019
1	Cytostatic AgentsIBA 10/2019
1	Carbon MonoxideIBA 01/2019
1	HDL CholesterolIBA 12/2018
1	C-Reactive ProteinIBA 12/2018
1	Apoptosis Regulatory ProteinsIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	AcidsIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	navitoclaxIBA 01/2017
1	Hydroxyeicosatetraenoic Acids (HETE)IBA 01/2017
1	tirbanibulinIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Contrast MediaIBA 01/2016
1	Coat Protein Complex I (COPI)IBA 01/2016
1	Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA 11/2014
1	Cysteine (L-Cysteine)FDA Link 11/2014
1	UbiquitinIBA 10/2014
1	Vesicle-Associated Membrane Protein 3IBA 08/2014
1	Tetanus ToxinIBA 08/2014
1	Antiviral Agents (Antivirals)IBA 08/2014
1	Small Interfering RNA (siRNA)IBA 08/2014
1	MicroRNAs (MicroRNA)IBA 08/2014
1	SNARE Proteins (SNAREs)IBA 08/2014
1	Fibronectins (Fibronectin)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 08/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2013
1	Guanosine Triphosphate (GTP)IBA 02/2013
1	isoquercitrinIBA 01/2012
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2012
1	CeramidesIBA 04/2006
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 06/2014
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Castration 01/2017
1	Fundoplication 06/2014
1	Glycemic Control 08/2013